威尔药业
(603351)
| 流通市值：36.96亿 | | | 总市值：36.96亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 169,396,027.95 | 207,182,857.12 | 433,461,319.29 | 423,865,188.4 |
| 交易性金融资产 | 5,000,000 | 5,000,000 | 5,000,000 | - |
| 应收票据及应收账款 | 199,371,403.46 | 239,630,675.62 | 241,493,069.47 | 200,271,523.03 |
| 应收账款 | 199,371,403.46 | 239,630,675.62 | 241,493,069.47 | 200,271,523.03 |
| 应收款项融资 | 53,757,010.74 | 53,314,640.85 | 32,024,746.83 | 50,984,667.88 |
| 预付款项 | 38,370,265.82 | 32,062,789.46 | 44,636,300.66 | 15,721,296.39 |
| 其他应收款合计 | 3,412,615.44 | 3,451,361.77 | 2,787,175.08 | 4,561,255.3 |
| 存货 | 212,348,653.98 | 214,136,683.38 | 196,371,877.45 | 206,114,012.37 |
| 其他流动资产 | 4,609,091.14 | 4,491,879.22 | 4,174,224.26 | 4,628,373.33 |
| 流动资产合计 | 686,265,068.53 | 759,270,887.42 | 959,948,713.04 | 906,146,316.7 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 115,002,415.25 | 115,002,415.25 | 116,826,088.66 | 116,826,088.66 |
| 固定资产 | 1,199,411,925.2 | 1,227,320,586.82 | 1,240,909,554.61 | 1,268,666,946.05 |
| 在建工程 | 213,542,299.2 | 177,521,457.91 | 154,896,942.54 | 140,659,754.69 |
| 使用权资产 | 18,049,653.12 | 18,689,641.77 | 20,017,693.58 | 22,280,586.74 |
| 无形资产 | 117,467,090.83 | 118,753,286.8 | 106,932,731.06 | 107,679,146.56 |
| 长期待摊费用 | 1,411,476.56 | 1,571,778.43 | 690,239.16 | 753,172.85 |
| 递延所得税资产 | 5,380,428.83 | 6,971,274.27 | 6,077,053 | 4,891,559.93 |
| 其他非流动资产 | 34,595,216.41 | 24,074,262.58 | 21,892,127.28 | 25,947,492.52 |
| 非流动资产合计 | 1,704,860,505.4 | 1,689,904,703.83 | 1,668,242,429.89 | 1,687,704,748 |
| 资产总计 | 2,391,125,573.93 | 2,449,175,591.25 | 2,628,191,142.93 | 2,593,851,064.7 |
| 流动负债: | | | | |
| 短期借款 | 273,798,695.82 | 353,301,755.54 | 496,503,428.89 | 476,330,758.06 |
| 交易性金融负债 | 4,306,179.76 | 4,216,167.74 | - | - |
| 应付票据及应付账款 | 93,256,496.55 | 113,615,994.49 | 101,261,626.01 | 112,426,895.48 |
| 应付账款 | 93,256,496.55 | 113,615,994.49 | 101,261,626.01 | 112,426,895.48 |
| 合同负债 | 8,547,798.12 | 11,321,034.63 | 12,829,197.28 | 6,432,153.01 |
| 应付职工薪酬 | 25,280,207.4 | 18,604,214.04 | 10,321,014.39 | 33,813,719.42 |
| 应交税费 | 16,130,423.22 | 11,178,402.62 | 15,249,313.45 | 8,308,670.31 |
| 其他应付款合计 | 32,643,088.13 | 40,595,750.35 | 24,856,040.77 | 25,706,721.06 |
| 一年内到期的非流动负债 | 47,480,845.57 | 45,520,283.2 | 28,493,475.9 | 31,805,778.53 |
| 其他流动负债 | 1,111,213.76 | 1,471,734.5 | 1,667,795.65 | 835,981.79 |
| 流动负债合计 | 502,554,948.33 | 599,825,337.11 | 691,181,892.34 | 695,660,677.66 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 52,000,000 | 52,000,000 |
| 租赁负债 | 9,949,354.7 | 13,407,233.83 | 14,520,235.24 | 14,536,974.23 |
| 递延收益 | 17,330,985.96 | 16,770,867.62 | 11,440,867.63 | 11,610,867.64 |
| 递延所得税负债 | 19,029,676.7 | 20,452,128.28 | 18,158,394.64 | 17,197,477 |
| 非流动负债合计 | 46,310,017.36 | 50,630,229.73 | 96,119,497.51 | 95,345,318.87 |
| 负债合计 | 548,864,965.69 | 650,455,566.84 | 787,301,389.85 | 791,005,996.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 135,439,132 | 135,439,132 | 135,439,132 | 135,439,132 |
| 资本公积 | 935,595,959.27 | 935,595,959.27 | 939,812,127.01 | 939,812,127.01 |
| 专项储备 | 2,510,394.71 | 1,731,455.64 | 1,196,687.59 | - |
| 盈余公积 | 67,719,566 | 67,719,566 | 67,719,566 | 67,719,566 |
| 未分配利润 | 691,270,592.09 | 648,011,477.43 | 690,126,106.34 | 652,492,066.47 |
| 归属于母公司股东权益合计 | 1,832,535,644.07 | 1,788,497,590.34 | 1,834,293,618.94 | 1,795,462,891.48 |
| 少数股东权益 | 9,724,964.17 | 10,222,434.07 | 6,596,134.14 | 7,382,176.69 |
| 股东权益合计 | 1,842,260,608.24 | 1,798,720,024.41 | 1,840,889,753.08 | 1,802,845,068.17 |
| 负债和股东权益合计 | 2,391,125,573.93 | 2,449,175,591.25 | 2,628,191,142.93 | 2,593,851,064.7 |
| 公告日期 | 2026-10-29 | 2026-08-22 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |